State Street Corporation 13D and 13G filings for Karyopharm Therapeutics Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-01-22 1:50 pm Sale |
2023-12-31 | 13G | Karyopharm Therapeutics Inc. KPTI |
STATE STREET CORP STT |
136,918 1.790% |
-10,573 (-7.17%) |
Filing |
| 2023-07-10 2:26 pm Sale |
2023-06-30 | 13G | Karyopharm Therapeutics Inc. KPTI |
STATE STREET CORP STT |
147,491 1.940% |
-404,978 (-73.30%) |
Filing |
| 2023-02-02 12:38 pm Purchase |
2022-12-31 | 13G | Karyopharm Therapeutics Inc. KPTI |
STATE STREET CORP STT |
552,469 7.320% |
184,890 (+50.30%) |
Filing |
| 2022-02-11 08:38 am Sale |
2021-12-31 | 13G | Karyopharm Therapeutics Inc. KPTI |
STATE STREET CORP STT |
367,579 7.300% |
-167,088 (-31.25%) |
Filing |
| 2021-10-12 12:23 pm Purchase |
2021-09-30 | 13G | Karyopharm Therapeutics Inc. KPTI |
STATE STREET CORP STT |
534,667 10.620% |
178,676 (+50.19%) |
Filing |
| 2021-02-11 3:09 pm Purchase |
2020-12-31 | 13G | Karyopharm Therapeutics Inc. KPTI |
STATE STREET CORP STT |
355,991 7.260% |
140,766 (+65.40%) |
Filing |